|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 15172289.9 (espacenet) (Federated) (European Patent Register), 20060517 | | Patent/reg. no. and date | DK/EP 2949668, 20190814 | | Publication date | 20151202 | | Priority no. and date | US 682332 P, 20050518 | | EP pub. no. and date |
EP 2949668 20151202 | | Effective date | | | Applicant/owner | Ablynx N.V., Technologiepark 21
9052 Ghent-Zwijnaarde, BE | | Applicant ref. no. | 1486204 | | Inventor | BEIRNAERT, Els Anna Alice, Markettestraat 20A
9881 Bellem, BE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07K 16/18 (2006.01) , C07K 16/24 (2006.01) | | Title | FORBEDREDE NANOBODIES TM MOD TUMORNEKROSEFAKTOR-ALFA | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
